Fractyl Health, Inc. Common Stock
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Fractyl Health, Inc. Common Stock generated cash of -$42,823,000, which is more than the previous year. Cash used in financing activities reached the amount of $27,437,000 last year. Net change in cash is therefore -$15,745,000.
Cash Flow
| 2019 | -27.73M | -97K | 15.16M |
|---|---|---|---|
| 2022 | -46.24M | -56K | 4.35M |
| 2023 | -42.82M | -359K | 27.43M |
GUTS Cash Flow Statement (2019 – 2023)
| 2023 | 2022 | 2019 | |
|---|---|---|---|
Cash at beginning of period | 49.26M | 95.47M | 18.45M |
Operating activities | |||
Net income | -77.09M | -46.45M | -30.59M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||
Depreciation and amortization | 286K | 452K | 893K |
Stock-based compensation expense | 4.29M | 3.13M | 2.51M |
| Deferred income tax benefit | 4.29M | 3.13M | 2.51M |
| Changes in operating assets and liabilities: | |||
Accounts receivable, net | -22K | 0 | 0 |
Inventories | -73K | 0 | 0 |
Accounts payable | -427K | 10K | 0 |
Cash generated by operating activities | -42.82M | -46.24M | -27.73M |
Investing activities | |||
Purchases Of Investments | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -359K | -56K | -97K |
Acquisitions Net | 0 | 0 | 0 |
Cash generated by investing activities | -359K | -56K | -97K |
Financing activities | |||
Common Stock Issued | -511K | 321K | 217K |
Payments for dividends | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 |
Repayments of term debt | 28.34M | 4.02M | 14.94M |
Cash used in financing activities | 27.43M | 4.35M | 15.16M |
Net Change In Cash | -15.74M | -46.20M | -12.66M |
Cash at end of period | 33.52M | 49.26M | 5.79M |